Pardes Biosciences Inc. (PRDS)
NASDAQ: PRDS
· Real-Time Price · USD
2.18
0.02 (0.93%)
At close: Aug 30, 2023, 9:59 PM
Pardes Biosciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -76.14M | -93M | -96.63M | -86.76M | -74.94M | -55.44M | -38.52M | -24.17M | -12.66M | -4.52M |
Depreciation & Amortization | -1.06 | -1.06 | -1.06 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 8.88M | 11.37M | 10.56M | 8.7M | 6.33M | 2.67M | 1.22M | 650K | 306K | 76K |
Other Working Capital | 3.16M | 14.26M | 12.38M | 2.99M | 2.18M | -2.04M | -377K | 2.27M | 1.89M | 1M |
Other Non-Cash Items | -3.32M | -2.48M | -1.06M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -8.16M | 5.96M | 15.16M | 2.05M | 1.54M | -769K | 379K | 3.38M | 2.82M | 699K |
Operating Cash Flow | -78.74M | -78.15M | -71.98M | -76.01M | -67.06M | -53.53M | -36.92M | -20.14M | -9.54M | -3.75M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -15.76M | -15.76M | -138.2 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 103.19M | 30.18M | 1.18 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 87.43M | 14.41M | -137.02 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 396.86K | 396.86K | -138 | 258.68M | 257.83M | 257.55M | 302.19M | 43.11M | 43.96M | 44.24M |
Financial Cash Flow | 396.86K | 396.86K | -138 | 258.68M | 257.83M | 257.55M | 302.19M | 43.11M | 43.96M | 44.24M |
Net Cash Flow | -128.33M | -200.75M | -209.39M | 182.67M | 190.77M | 204.02M | 265.27M | 22.97M | 34.42M | 40.49M |
Free Cash Flow | -78.74M | -78.15M | -71.98M | -76.01M | -67.06M | -53.53M | -36.92M | -20.14M | -9.54M | -3.75M |